CareTrust REIT (CTRE) AI Stock Analysis

• Market Cap: $7.94B
• Dividend Yield: 3.58%
• Average Volume (3M): 1.86M
• Price to Earnings (P/E): 26.5
• Beta (1Y): 0.19
• Revenue Growth: 59.25%
• EPS Growth: 88.37%
• Country: US
• Employees: 21
• Sector: Real Estate
• Sector Strength: 53
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.35
• Shares Outstanding: 223,300,320
• 10 Day Avg. Volume: 2,013,348
• 30 Day Avg. Volume: 1,861,866
• PEG Ratio: 0.54
• Price to Book (P/B): 1.44
• Price to Sales (P/S): 18.34
• P/FCF Ratio: 17.73
• Enterprise Value/Market Cap: 0.95
• Enterprise Value/Revenue: 21.47
• Enterprise Value/Gross Profit: 22.04
• Enterprise Value/Ebitda: 19.96
• 1Y Price Target: $37.43
• Price Target Upside: 3.54% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 7
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 79 Outperform
• Price Target: $39.00 ▲(7.88% Upside)

CareTrust REIT's strong financial performance and strategic growth initiatives, particularly in the U.K. and SHOP segments, are key strengths. Positive technical indicators support the stock's upward momentum. However, the high P/E ratio suggests potential overvaluation, which slightly tempers the overall score.

Positive Factors

Revenue Growth

The significant increase in revenue highlights strong market demand and effective business strategies, indicating robust growth potential.

Strong Financial Position

Strong liquidity and low leverage provide financial flexibility for future investments and stability, supporting long-term growth.

Investment Pipeline

A robust investment pipeline ensures continued growth opportunities, enhancing the company's ability to expand its asset base and revenue streams.

Negative Factors

Increased G&A Expenses

Rising G&A expenses could pressure margins and profitability, potentially impacting long-term financial performance if not managed effectively.

Regulatory Uncertainty

Regulatory uncertainties pose risks to revenue stability and profitability, affecting the company's ability to predict and manage future financial outcomes.

Leadership Transition

Leadership changes can lead to strategic shifts and operational disruptions, potentially impacting the company's long-term strategic direction and performance.

CareTrust REIT Business Overview & Revenue Model

Company Description

CareTrust REIT (CTRE) is a real estate investment trust that focuses on the ownership and management of senior housing and healthcare properties across the United States. The company primarily invests in skilled nursing facilities, assisted living facilities, and other healthcare-related properties, catering to the growing demand for senior care services. CareTrust REIT aims to provide stable returns to its investors by acquiring and leasing properties to experienced operators, while also ensuring high-quality care for residents.

How the Company Makes Money

CareTrust REIT generates revenue primarily through long-term leases with skilled nursing and senior housing operators. The company acquires properties and then leases them to operators under triple-net lease agreements, where the operators are responsible for property expenses such as maintenance, taxes, and insurance. This structure allows CareTrust to earn steady rental income while minimizing its operational liabilities. Additionally, CareTrust may benefit from rent escalators built into its leases, which provide incremental revenue growth over time. Significant partnerships with well-established healthcare operators enhance its portfolio's stability and performance, contributing to consistent cash flow and dividends for shareholders.

CareTrust REIT Financial Statement Overview

Summary

CareTrust REIT exhibits strong financial health with robust revenue growth and profitability. The balance sheet reflects financial stability with low leverage, while cash flow generation is solid. Continued focus on cost management and maintaining cash flow efficiency will be crucial for sustaining growth.

Income Statement

CareTrust REIT demonstrates strong profitability with a high gross profit margin of 97.61% and a net profit margin of 68.96% in the TTM period. Revenue growth is robust at 24.81%, indicating a positive trajectory. However, the EBIT margin has decreased compared to previous years, suggesting potential cost management issues.

Balance Sheet

The company maintains a solid equity base with a low debt-to-equity ratio of 0.22 in the TTM period, reflecting financial stability. Return on equity is moderate at 7.96%, indicating efficient use of equity. However, the equity ratio is not explicitly provided, which limits a full assessment of asset financing.

Cash Flow

Cash flow performance is strong with a free cash flow growth rate of 11.06% in the TTM period. The free cash flow to net income ratio is high at 95.70%, indicating effective cash generation relative to earnings. However, the operating cash flow to net income ratio is not available, which could provide additional insights into cash flow efficiency.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	352.32M	228.26M	198.60M	187.51M	190.19M	175.69M
Gross Profit	343.27M	214.71M	189.01M	178.13M	186.62M	170.98M
EBITDA	379.04M	211.54M	145.80M	72.88M	151.05M	157.35M
Net Income	261.38M	125.08M	53.73M	-7.51M	71.98M	80.87M
Balance Sheet
Total Assets	5.09B	3.44B	2.08B	1.62B	1.64B	1.50B
Cash, Cash Equivalents and Short-Term Investments	712.48M	213.82M	294.45M	13.18M	19.89M	18.92M
Total Debt	893.79M	396.93M	595.60M	719.50M	673.40M	545.59M
Total Liabilities	1.07B	507.63M	666.12M	771.41M	725.09M	589.42M
Stockholders Equity	3.99B	2.91B	1.42B	849.37M	915.76M	914.14M
Cash Flow
Free Cash Flow	334.41M	236.20M	143.79M	137.12M	150.86M	137.44M
Operating Cash Flow	348.28M	244.25M	154.77M	144.41M	156.87M	145.74M
Investing Cash Flow	-1.59B	-1.51B	-267.81M	-127.40M	-192.63M	-41.58M
Financing Cash Flow	1.57B	1.19B	394.32M	-23.73M	36.74M	-105.56M

CareTrust REIT Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 36.15
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTRE, the sentiment is Positive. The current price of 36.15 is above the 20-day moving average (MA) of 34.74, above the 50-day MA of 34.37, and above the 200-day MA of 30.03, indicating a bullish trend. The MACD of 0.42 indicates Negative momentum. The RSI at 60.92 is Neutral, neither overbought nor oversold. The STOCH value of 82.58 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTRE.

CareTrust REIT Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	79 Outperform	$7.94B	26.50	8.13%	3.58%	59.25%	88.37%
OHI	76 Outperform	$12.60B	23.95	11.28%	6.16%	13.50%	31.56%
NHI	75 Outperform	$3.58B	24.05	10.87%	4.81%	8.04%	9.20%
SBRA	74 Outperform	$4.70B	25.92	6.29%	6.59%	8.12%	75.95%
AHR	70 Neutral	$8.17B	340.34	1.12%	2.02%	11.80%	―
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
HR	57 Neutral	$6.30B	―	-7.26%	6.59%	-6.59%	33.35%

CareTrust REIT Corporate Events

CareTrust REIT Reports Strong Q3 2025 Results

CareTrust REIT, Inc. is a real estate investment trust focused on the ownership, acquisition, development, and leasing of healthcare-related properties, including skilled nursing and seniors housing facilities, across the United States and the United Kingdom.

CareTrust REIT Reports Strong Q3 2025 Financial Results

CareTrust REIT reported strong financial results for the third quarter of 2025, with significant increases in net income, normalized FFO, and normalized FAD compared to the previous year. The company closed $59.4 million in investments and raised $736 million through a public stock offering, enhancing its liquidity and investment pipeline. CareTrust’s strategic moves, including the integration of UK acquisitions and maintaining a 100% rent collection rate, position it for continued growth into 2026, as highlighted by its updated guidance and robust investment pipeline.

The most recent analyst rating on (CTRE) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

CareTrust REIT Expands Board with New Director

On October 21, 2025, CareTrust REIT‘s Board of Directors expanded from five to six members, appointing Gregory K. Stapley as a director effective January 1, 2026. Stapley, a former President and CEO of CareTrust, brings extensive leadership and expertise in the healthcare real estate sector, which is expected to benefit the company’s growth strategy. Additionally, the Board approved amendments to the company’s bylaws to align with SEC universal proxy rules and update nomination procedures, enhancing governance and operational efficiency.

The most recent analyst rating on (CTRE) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

CareTrust REIT Announces CFO Retirement Plan

On September 19, 2025, CareTrust REIT announced the planned retirement of its Chief Financial Officer, William M. Wagner, effective December 31, 2025. Derek Bunker, who has been with the company since June 2025, will succeed Mr. Wagner as CFO starting January 1, 2026. Mr. Bunker brings over a decade of experience in healthcare leadership and finance, aligning with CareTrust’s mission and strategy for future growth. The transition is part of a broader plan to strengthen the company’s leadership, with Lauren Beale, the Chief Accounting Officer, taking on expanded responsibilities.

The most recent analyst rating on (CTRE) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

CareTrust REIT Completes Major Stock Issuance

On August 12, 2025, CareTrust REIT, Inc. entered into an underwriting agreement with major financial institutions to sell 20,000,000 shares of its common stock at $32.00 per share, with an option for an additional 3,000,000 shares, which was fully exercised the next day. The issuance of these shares, completed on August 14, 2025, was part of a strategic move to enhance the company’s financial positioning and potentially expand its operations within the healthcare real estate sector.

The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.

CareTrust REIT’s Earnings Call Highlights Growth and Expansion

The recent earnings call for CareTrust REIT painted a picture of a company on the rise, with notable achievements in investment growth and revenue increases. The sentiment was largely positive, buoyed by strategic market expansion efforts, particularly in the UK. However, there were some cautionary notes regarding increased expenses and potential future regulatory risks. Overall, the company’s robust performance and strategic initiatives suggest a promising outlook.

CareTrust REIT Reports Strong Q2 2025 Results

CareTrust REIT, Inc. is a publicly-traded real estate investment trust that specializes in the ownership, acquisition, development, and leasing of healthcare-related properties, including skilled nursing and seniors housing facilities, with operations in both the United States and the United Kingdom.